Blood Journal
Leading the way in experimental and clinical research in hematology

San-Miguel J, Bladé J, Shpilberg O, et al. Phase 2 randomized study of bortezomib-melphalan-prednisone with or without siltuximab (anti–IL-6) in multiple myeloma. Blood. 2014;123(26):4136-4142.

In the 26 June 2014 issue, the article by San-Miguel et al beginning on page 4136 was listed in the wrong section of Blood. It appeared in the “Myeloid Neoplasia” section, but it should have appeared in the “Clinical Trials and Observations” section. This error has been corrected in the online version, which now differs from the print version.